Can patients be accurately assessed for familial hypercholesterolaemia in primary care?

Heart Lung and Circulation

Volumn 23, Issue 12, 2014, Pages 1153-1157

  Bell, Damon A ^a,b   Kirke, Andrew B ^c   Barbour, Rita ^c   Southwell, Lynda ^b   Pang, Jing ^a,b   Burrows, Sally ^a   Watts, Gerald F ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Diagnostic accuracy; Familial hypercholesterolaemia; Preventative cardiology; Primary care; Screening

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE CLASSIFICATION; DUTCH LIPID CLINIC NETWORK CRITERIA SCORE; ENZYME ASSAY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; GENERAL PRACTITIONER; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MEDICAL SPECIALIST; PRIMARY MEDICAL CARE; PROBABILITY; RATING SCALE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; GENETICS; HYPERLIPOPROTEINEMIA TYPE II; MIDDLE AGED; PRIMARY HEALTH CARE;

EDUCATION, MEDICAL, CONTINUING; FEMALE; GENETIC TESTING; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED; PRIMARY HEALTH CARE;

EID: 84912531063     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2014.06.015     Document Type: Article

References (22)

1. Watts G.F., Sullivan D.R., Poplawski N., van Bockxmeer F., Hamilton-Craig I., Clifton P.M., et al. Familial hypercholesterolaemia: A model of care for Australasia. Atheroscler Suppl 2011, 12(2):221-231.
2. Nordestgaard B.G., Chapman M.J., Humphries S.E., Ginsberg H.N., Masana L., Descamps O.S., et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society. Eur Heart J 2013.
3. Wilson J.M., Jungner Y.G. Principles and practice of mass screening for disease 1968, Geneva World Health Organization.
4. Bender R., Bell D.A., Hooper A.J., Edwards G., van Bockxmeer F.M., Watts G.F., et al. Screening for familial hypercholesterolaemia. Pathology (Phila) 2012, 44(2):122-128.
5. Kirke A., Watts G.F., Emery J. Detecting familial hypercholesterolaemia in general practice. Aust Fam Physician 2012, 41(12):965-968.
6. World Health Organisation. Familial Hypercholesterolaemia (FH): Report of a second WHO consultation. Geneva, 1999.
7. Benn M., Watts G.F., Tybjaerg-Hansen A., Nordestgaard B.G. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. The Journal of Clinical Endocrinology and Metabolism 2012, 97(11):3956-3964.
8. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18(6):499-502.
9. Hooper A.J., Nguyen L.T., Burnett J.R., Bates T.R., Bell D.A., Redgrave T.G., et al. Genetic analysis of familial hypercholesterolaemia in Western Australia. Atherosclerosis 2012, 224(2):430-434.
10. NICE. Clinical guideline 71: identification and management of familial hypercholesterolaemia. 2008. http://www.nice.org.uk/nicemedia/pdf/CG071NICEGuideline.pdf.
11. Humphries S.E., Hadfield G. Identifying patients with familial hypercholesterolaemia in primary care. Heart 2008, 94(6):695-696.
12. Qureshi N., Humphries S.E., Seed M., Rowlands P., Minhas R. Identification and management of familial hypercholesterolaemia: what does it mean to primary care?. Br J Gen Pract 2009, 59(567):773-776.
13. Tyerman P.F., Tyerman G.V. Another way of screening for familial hypercholesterolaemia. BMJ 2002, 325(7359):340.
14. Watts G.F., Juniper A., van Bockxmeer F., Ademi Z., Liew D., O'Leary P. Familial hypercholesterolaemia: a review with emphasis on evidence for treatment, new models of care and health economic evaluations. Int J Evid Based Health 2012, 10(3):211-221.
15. Marks D., Wonderling D., Thorogood M., Lambert H., Humphries S.E., Neil H.A. Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia. BMJ 2002, 324(7349):1303.
16. Daniels S.R., Gidding S.S., de Ferranti S.D., National Lipid Association Expert Panel on Familial H. Pediatric aspects of familial hypercholesterolemias: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 2011, 5(3 Suppl):S30-S37.
17. Watts G.F., Gidding S., Wierzbicki A.S., Toth P.P., Alonso R., Brown W.V., et al. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Int J Cardiol 2014, 171(3):309-325.
18. Muir L.A., George P.M., Laurie A.D., Reid N., Whitehead L. Preventing cardiovascular disease: a review of the effectiveness of identifying the people with familial hypercholesterolaemia in New Zealand. NZ Med J 2010, 123(1326):97-102.
19. Bell D.A., Garton-Smith J., Vickery A., Kirke A.B., Pang J., Bates T.R., et al. Familial Hypercholesterolaemia in Primary Care: Knowledge and Practices among General Practitioners in Western Australia. Heart, Lung and Circulation 2013.
20. Foody J.M. Familial Hypercholesterolemia: An Under-recognized but Significant Concern in Cardiology Practice. Clin Cardiol 2014, 37(2):119-125.
21. Jervis L.H.M., Bell D., Krass I., Watts G.F. An audit of pharmacists' knowledge of familial hypercholesterolaemia: implications for community healthcare. Australian Pharmacist 2013 July.
22. Bell D.A., Bender R., Hooper A.J., McMahon J., Edwards G., van Bockxmeer F.M., et al. Impact of interpretative commenting on lipid profiles in people at high risk of familial hypercholesterolaemia. Clin Chim Acta 2013, 422:21-25.